| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.61 | 0.03 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.49 | 0.08 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.29 | 1e-07 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.21 | 3e-05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.19 | 0.002 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.003 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.18 | 6e-08 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-08 |